Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M0QQ
|
|||
Former ID |
DIB021237
|
|||
Drug Name |
XMD8-92
|
|||
Synonyms |
XMD 8-92
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C26H30N6O3
|
|||
Canonical SMILES |
CCOC1=C(C=CC(=C1)N2CCC(CC2)O)NC3=NC=C4C(=N3)N(C5=CC=CC=C5C(=O)N4C)C
|
|||
InChI |
1S/C26H30N6O3/c1-4-35-23-15-17(32-13-11-18(33)12-14-32)9-10-20(23)28-26-27-16-22-24(29-26)30(2)21-8-6-5-7-19(21)25(34)31(22)3/h5-10,15-16,18,33H,4,11-14H2,1-3H3,(H,27,28,29)
|
|||
InChIKey |
QAPAJIZPZGWAND-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1234480-50-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:60325
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Doublecortin-like kinase 2 (DCLK2) | Target Info | Inhibitor | [1] |
Extracellular signal-regulated kinase 5 (ERK5) | Target Info | Inhibitor | [1] | |
Non-receptor tyrosine-protein kinase TNK1 (TNK1) | Target Info | Inhibitor | [1] | |
Polo-like kinase 4 (PLK4) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell. 2010 Sep 14;18(3):258-67. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.